AAN 2024: AbbVie highlights long-term safety of atogepant in migraine prevention
Some of the oral preventive treatments have been associated with potential adverse events (AEs) or are contraindicated.
Some of the oral preventive treatments have been associated with potential adverse events (AEs) or are contraindicated.